Dr Daniel Turnham, (research associate, Cardiff University, UK), opened with a talk on a novel antibody-drug conjugate which exploits the high expression of receptor-for-advanced-glycation-end-products (RAGE) in metastatic prostate cancer. The gene discussed is AGER; the disease is metastatic prostate carcinoma.